Xizang Haisco Pharmaceutical Group Co Ltd Capital Reinvestment Ratio
Xizang Haisco Pharmaceutical Group Co Ltd capital reinvestment ratio. Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Capital Reinvestment Ratio of 1.83x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥39.68 Million) in capital expenditures (CN¥72.46 Million). See how much free cash does Xizang Haisco Pharmaceutical Group Co Lt generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Capital reinvestment ratio of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. This chart tracks Xizang Haisco Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 18 annual periods. See 002653 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Xizang Haisco Pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (2008–2025)
Xizang Haisco Pharmaceutical Group Co Ltd capital reinvestment ratio by year from 2008 to 2025. For the full cash flow conversion analysis, see Xizang Haisco Pharmaceutical Group Co Lt cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | CN¥786.00 Million | CN¥331.98 Million | ▼ -57.6% |
| 2024 | 1.00x | CN¥442.05 Million | CN¥440.65 Million | ▲ +14.6% |
| 2023 | 0.87x | CN¥449.58 Million | CN¥391.01 Million | ▼ -88.3% |
| 2022 | 7.41x | CN¥94.55 Million | CN¥700.17 Million | ▼ -62.3% |
| 2021 | 19.63x | CN¥35.80 Million | CN¥702.94 Million | ▲ +572.9% |
| 2020 | 2.92x | CN¥206.21 Million | CN¥601.72 Million | ▲ +282.7% |
| 2019 | 0.76x | CN¥764.26 Million | CN¥582.68 Million | ▲ +2.4% |
| 2018 | 0.74x | CN¥472.61 Million | CN¥351.98 Million | ▼ -25.8% |
| 2017 | 1.00x | CN¥391.81 Million | CN¥393.26 Million | ▲ +97.2% |
| 2016 | 0.51x | CN¥409.20 Million | CN¥208.24 Million | ▼ -20.5% |
| 2015 | 0.64x | CN¥443.03 Million | CN¥283.68 Million | ▲ +37.0% |
| 2014 | 0.47x | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥94.45 Million | CN¥37.38 Million | — |